Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Ju Fu Tang Biotech Holdings Co's share price is HK$0.102.
Ju Fu Tang Biotech Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was HK$0.12. Hence, Ju Fu Tang Biotech Holdings Co's PS Ratio for today is 0.83.
The historical rank and industry rank for Ju Fu Tang Biotech Holdings Co's PS Ratio or its related term are showing as below:
HKSE:08217'
s PS Ratio Range Over the Past 10 Years
Min: 0.06 Med: 0.33 Max: 98.25
Current: 0.83
During the past 13 years, Ju Fu Tang Biotech Holdings Co's highest PS Ratio was 98.25. The lowest was 0.06. And the median was 0.33.
HKSE:08217's PS Ratio is ranked worse than 50.11% of 1772
companies
in the Construction industry
Industry Median: 0.88
vs HKSE:08217: 0.83
During the past 13 years, Ju Fu Tang Biotech Holdings Co's highest 3-Year average Revenue per Share Growth Rate was 66.50% per year. The lowest was -59.10% per year. And the median was -32.70% per year.
Ju Fu Tang Biotech Holdings Co (HKSE:08217) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Ju Fu Tang Biotech Holdings Co PS Ratio Related Terms
Ju Fu Tang Biotech Holdings Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Engineering & Construction subindustry, Ju Fu Tang Biotech Holdings Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ju Fu Tang Biotech Holdings Co PS Ratio vs Construction Industry
For the Construction industry and Industrials sector, Ju Fu Tang Biotech Holdings Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Ju Fu Tang Biotech Holdings Co's PS Ratio falls into.
Ju Fu Tang Biotech Holdings Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Ju Fu Tang Biotech Holdings Co's Share Price of today is HK$0.102.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ju Fu Tang Biotech Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was HK$0.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Ju Fu Tang Biotech Holdings Co (HKSE:08217) has a PS Ratio of 0.83 as of Aug. 15, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. This is 152% above median its historical median of 0.33. Over the past decade, Ju Fu Tang Biotech Holdings Co's PS Ratio has ranged from 0.06 to 98.25. According to the industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #888 out of 1772 companies in the Construction industry, placing it in the top 50.1%.
Is Ju Fu Tang Biotech Holdings Co's PS Ratio too high?
Ju Fu Tang Biotech Holdings Co's current PS Ratio of 0.83 is 152% above median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 98.25. The Construction industry median PS Ratio is 0.88. Ju Fu Tang Biotech Holdings Co's value of 0.83 is 5.7% below this industry median. Based on the distribution chart, Ju Fu Tang Biotech Holdings Co ranks #888 out of 1772 companies in the Construction industry, which is below the industry midpoint. Overall, Ju Fu Tang Biotech Holdings Co has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ju Fu Tang Biotech Holdings Co's PS Ratio compare to PWR and FIX?
According to the Construction industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #888 out of 1772 companies for PS Ratio. This places Ju Fu Tang Biotech Holdings Co in the lower half of its industry. The industry median PS Ratio is 0.88. Ju Fu Tang Biotech Holdings Co's value of 0.83 is 5.7% below this benchmark. Historically, Ju Fu Tang Biotech Holdings Co's own PS Ratio has ranged from 0.06 to 98.25 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 0.88, Ju Fu Tang Biotech Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Construction company?
The median PS Ratio among Construction companies is 0.88, based on 1,772 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ju Fu Tang Biotech Holdings Co's current PS Ratio of 0.83 is 5.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. For the Construction industry, the median PS Ratio is 0.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ju Fu Tang Biotech Holdings Co's current PS Ratio is 0.83, which is 152% above median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ju Fu Tang Biotech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co (HKSE:08217) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.10 — trading 32% below its estimated fair value. The current PS Ratio is 0.83, which is 152% above median its 10-year median of 0.33 and 5.7% below the Construction industry median of 0.88. Ju Fu Tang Biotech Holdings Co's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Ju Fu Tang Biotech Holdings Co (HKSE:08217), the current PS Ratio is 0.83 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ju Fu Tang Biotech Holdings Co (HKSE:08217) Overvalued in 2026?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co stock appears to be undervalued.
The current stock price of HK$0.10 is trading 32% below its estimated GF Value™ of HK$0.15.
GuruFocus considers Ju Fu Tang Biotech Holdings Co to be Possible Value Trap.
Key valuation signals for HKSE:08217:
PS Ratio: 0.83 (152% above median its 10-year median of 0.33)
GF Value™: HK$0.15 vs. price of HK$0.10 (32% below fair value)
Industry Position: 5.7% below the Construction median (#888 of 1772)
No single metric tells the full story. See the HKSE:08217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ju Fu Tang Biotech Holdings Co Ltd, formerly known as WMHW Holdings Ltd, is an investment holding company operating through its subsidiaries. It engaged in the provision of construction works and investment holding.
35GF Score
Get the complete analysis for HKSE:08217
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08217 has been successfully added to your 
